BridgeMD
New treatment option for Mild Traumatic Brain Injury
Official title The Effect of Creatine Monohydrate on Persistent Post-concussive Symptoms
ClinicalTrials.gov ID: NCT05562232
What this study is testing
- What it's testing
- The purpose of this study, is to investigate whether creatine monohydrate as a supplement reduces the number and severity of symptoms in patients with persistent post-concussive symptoms through self-reported post-concussion symptoms questionnaires.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 45
You may be able to join if
- Have had PPCS for a minimum of six months and a maximum of 18 months at the start of the study.
- Being between 20 and 45 years of age
You likely can't join if
- Elite athletes, as well as people who in general is physical active, at an intensity of moderat to high, for more than ten hours a week on average.
- Participation in other interventions/treatment that could affect this study
- Have had PPCS in:
- =\<6 months
- =\>18 months
- Pregnant
The study team makes the final eligibility decision.
Where it's taking place
- Odense, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Odense, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.